TECH OFFER

Drug Delivery Composition Comprising Polymerlipid Hybrid (PLH) Microparticles

KEY INFORMATION

TECHNOLOGY CATEGORY:
Healthcare - Pharmaceuticals & Therapeutics
TECHNOLOGY READINESS LEVEL (TRL):
LOCATION:
Australia
ID NUMBER:
TO116956

TECHNOLOGY OVERVIEW

Lipid systems have been widely used in drug delivery applications, however issues arise due to instability, insufficient drug loading and burst release of encapsulated drug molecules. Alternatively, established polymeric nanoparticles can control drug release and sustain circulation whilst providing higher stability in biological fluids, however, the biocompatibility is not as high as lipid systems.

We have developed novel PLGAlipid hybrid (PLH) microparticles that combine the stabilising and controlled delivery characteristics of PLGA nanoparticles with the solubilizing effect of lipid droplets. This novel drug delivery formulation can be used in a wide range of therapeutic applications, including combination therapy with tuneable dispersion and controlled drug release.

TECHNOLOGY FEATURES & SPECIFICATIONS

The PLH microparticles increase the solubility of poorly water soluble drugs by dissolving the drug in the hydrophobic PLGA nanoparticles and lipid droplets. This drug delivery technology has the potential to:

  • mimic the pharmaceutical food affect, thereby removing the need to take medication with a meal and increasing the therapeutic value of a range of drugs
  • for a mono-therapy, deliver the drug through 2 different mechanisms and hence increase uptake, change the absorption dynamics and improve pharmacokinetics
  • for a combination therapy, deliver 2 separate drugs in a single formulation.

The PLH microparticles have the potential to be used by the pharmaceutical industry as a drug carrier for the delivery of a wide range of hydrophobic drugs. Routes for administration include, oral, implantable and inhalation.

POTENTIAL APPLICATIONS

This technology is relevent for:

  • Pharmaceutical companies
  • Drug delivery & formulation companies

Market Trends & Opportunities

The team is seeking commercial partners for drug delivery and formulation co-development and licensing opportunities.

Unique Value Proposition

A novel hybrid drug delivery formulation that can be used in a wide range of therapeutic applications.

  • Controlled drug encapsulation, release and delivery
  • Expanded pharmaceutical applications
  • Increased solubility of drugs
  • Drug carrier for a wide range of hydrophobic drugs
RELATED TECH OFFERS
ForodermTM: A Novel Elongate Microparticle (EMP)-based Bioactive Delivery System
Inulin-lipid Hybrid (ILH) Technology
Liquid Crystal Nanoparticles (LCNP) Enhances Antimicrobial Efficacy
Transdermal Photothermal Therapy for Obesity, Metabolic Diseases, and Body Sculpting
Ore-lax: Microemulsion-Based Gel for Muscle Pain Relief
Activated-siRNA Microneedles for Pathological Scar Treatment
Cosmetic & Fragrance Applications of CaproGlu Bioadhesives
Leapfrogging Aquaculture Side-stream Wastage
Efficient & Sustainable Method for Algae-based Carotenoid
Using Natural Products to Improve Skin Microflora for Atopic Dermatitis